Furthermore, treatment of neuroblastoma cells with the inflammatory cytokine interleukin-1-beta (IL-1β), a common target of NF-kB signaling and the most highly up-regulated gene in our study, failed to protect them from 6-OHDA toxicity (Fig. S2D). The gene discussed is NFKB1; the disease is neuroblastoma.